Australia markets open in 7 hours 21 minutes

Antisense Therapeutics Limited (ANP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.11000.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 73.57M
Enterprise value 50.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.08
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.28

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 3-38.89%
S&P500 52-week change 3-2.16%
52-week high 30.3500
52-week low 30.0730
50-day moving average 30.0881
200-day moving average 30.1374

Share statistics

Avg vol (3-month) 3570.01k
Avg vol (10-day) 3544.57k
Shares outstanding 5668.79M
Implied shares outstanding 6N/A
Float 8510.11M
% held by insiders 119.28%
% held by institutions 15.14%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 306 Nov 2013

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,423.14%

Management effectiveness

Return on assets (ttm)-30.84%
Return on equity (ttm)-52.50%

Income statement

Revenue (ttm)631.52k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)26.00%
Gross profit (ttm)467.46k
EBITDA -8.98M
Net income avi to common (ttm)-9M
Diluted EPS (ttm)-0.0150
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.48M
Total cash per share (mrq)0.04
Total debt (mrq)268.25k
Total debt/equity (mrq)1.12
Current ratio (mrq)25.91
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-7.57M
Levered free cash flow (ttm)-4.2M